AAAAAA

   
Results: 1-18 |
Results: 18
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)
Authors: Skarlos, DV Samantas, E Briassoulis, E Panoussaki, E Pavlidis, N Kalofonos, HP Kardamakis, D Tsiakopoulos, E Kosmidis, P Tsavdaridis, D Tzitzikas, J Tsekeris, P Kouvatseas, G Zamboglou, N Fountzilas, G
Citation: Dv. Skarlos et al., Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG), ANN ONCOL, 12(9), 2001, pp. 1231-1238
Thalidomide and dexamethasone combination for refractory multiple myeloma
Authors: Dimopoulos, MA Zervas, K Kouvatseas, G Galani, E Grigoraki, V Kiamouris, C Vervessou, E Samantas, E Papadimitriou, C Economou, O Gika, D Panayiotidis, P Christakis, I Anagnostopoulos, N
Citation: Ma. Dimopoulos et al., Thalidomide and dexamethasone combination for refractory multiple myeloma, ANN ONCOL, 12(7), 2001, pp. 991-995
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
Authors: Christodoulou, C Bafaloukos, D Kosmidis, P Samantas, E Bamias, A Papakostas, P Karabelis, A Bacoyiannis, C Skarlos, DV
Citation: C. Christodoulou et al., Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases, ANN ONCOL, 12(2), 2001, pp. 249-254
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer
Authors: Razis, E Dimopoulus, AM Bafaloukos, D Papadimitriou, C Kalogera-Fountzila, A Kalofonos, H Briassoulis, E Samantas, E Keramopoulos, A Pavlidis, N Kosmidis, P Fountzilas, G
Citation: E. Razis et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer, CANCER INV, 19(2), 2001, pp. 137-144
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group
Authors: Pectasides, D Kalofonos, HP Samantas, E Nicolaides, C Papacostas, P Onyenadum, A Visvikis, A Skarlos, D Fountzilas, G
Citation: D. Pectasides et al., An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group, ANTICANC R, 21(4B), 2001, pp. 3005-3010
Correlation of in vitro cytotoxicity and clinical response to chemotherapyin ovarian and breast cancer patients
Authors: Agiostratidou, G Sgouros, I Galani, E Voulgari, A Chondrogianni, N Samantas, E Dimopoulos, MA Skarlos, D Gonos, ES
Citation: G. Agiostratidou et al., Correlation of in vitro cytotoxicity and clinical response to chemotherapyin ovarian and breast cancer patients, ANTICANC R, 21(1A), 2001, pp. 455-459
Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status
Authors: Janinis, J Efstathiou, E Panopoulos, C Samantas, E Aravantinos, G Christodoulou, C Skarlos, D
Citation: J. Janinis et al., Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status, MED ONCOL, 17(2), 2000, pp. 106-110
Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial
Authors: Kosmidis, P Mylonakis, N Skarlos, D Samantas, E Dimopoulos, M Papadimitriou, C Kalophonos, C Pavlidis, N Nikolaidis, C Papaconstantinou, C Fountzilas, G
Citation: P. Kosmidis et al., Paclitaxel (175 mg/m(2)) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m(2))plus carboplatin (6 AUG) in advanced non-small-cell lung cancer (NSCLC): A multicenter randomized trial, ANN ONCOL, 11(7), 2000, pp. 799-805
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group
Authors: Nicolaides, C Dimopoulos, MA Samantas, E Bafaloukos, D Kalofonos, C Fountzilas, G Razi, E Kosmidis, P Pavlidis, N
Citation: C. Nicolaides et al., Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 11(7), 2000, pp. 873-875
Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study
Authors: Samantas, E Kalofonos, H Linardou, H Nicolaides, C Mylonakis, N Fountzilas, G Kosmidis, P Skarlos, D
Citation: E. Samantas et al., Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study, ANN ONCOL, 11(11), 2000, pp. 1395-1397
Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study
Authors: Briasoulis, E Kalofonos, H Bafaloukos, D Samantas, E Fountzilas, G Xiros, N Skarlos, D Christodoulou, C Kosmidis, F Pavlidis, N
Citation: E. Briasoulis et al., Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study, J CL ONCOL, 18(17), 2000, pp. 3101-3107
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results
Authors: Kosmidis, P Mylonakis, N Dimopoulos, A Pavlidis, N Fountzilas, G Samantas, E Dimitriadis, K Kalophonos, C Tsavdaridis, D Skarlos, D
Citation: P. Kosmidis et al., Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results, SEMIN ONCOL, 27(1), 2000, pp. 3-8
Postoperative radiation and concomitant bolus fluorouracil with or withoutadditional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Zisiadis, A Dafni, U Konstantaras, C Hatzitheoharis, G Liaros, A Athanassiou, E Dombros, N Dervenis, C Basdanis, G Gamvros, O Souparis, A Briasoulis, E Samantas, E Kappas, A Kosmidis, P Skarlos, D Pavlidis, N
Citation: G. Fountzilas et al., Postoperative radiation and concomitant bolus fluorouracil with or withoutadditional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase III study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(6), 1999, pp. 671-676
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Stathopoulos, G Nicolaides, C Kalogera-Fountzila, A Kalofonos, H Nikolaou, A Bacoyiannis, C Samantas, E Papadimitriou, C Kosmidis, P Daniilidis, J Pavlidis, N
Citation: G. Fountzilas et al., Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(4), 1999, pp. 475-478
A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma
Authors: Xiros, N Economopoulos, T Fountzilas, G Pavlidis, N Samantas, E Raptis, S
Citation: N. Xiros et al., A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma, HAEMATOLOG, 84(2), 1999, pp. 189-190
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis - A study of the Hellenic Cooperative Oncology Group
Authors: Skarlos, DV Samantas, E Pectasides, D Pavlidis, N Kalofonos, C Klouvas, G Panoussaki, E Tsiakopoulos, E Poulakis, N Fountzilas, G
Citation: Dv. Skarlos et al., Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis - A study of the Hellenic Cooperative Oncology Group, AM J CL ONC, 22(1), 1999, pp. 87-93
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer
Authors: Samantas, E Skarlos, DV Pectasides, D Nicolaides, P Kalofonos, H Mylonakis, N Vardoulakis, T Kosmidis, P Pavlidis, N Fountzilas, G
Citation: E. Samantas et al., Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer, LUNG CANC, 23(2), 1999, pp. 159-168
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial
Authors: Alexopoulos, K Kouroussis, C Androulakis, N Papadakis, E Vaslamatzis, M Kakolyris, S Samelis, G Patila, E Vossos, A Samantas, E Georgoulias, V
Citation: K. Alexopoulos et al., Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial, CANC CHEMOT, 43(3), 1998, pp. 257-262
Risultati: 1-18 |